Neurofibromatosis type 1 is not associated with subarachnoid haemorrhage
- PMID: 28575128
- PMCID: PMC5456355
- DOI: 10.1371/journal.pone.0178711
Neurofibromatosis type 1 is not associated with subarachnoid haemorrhage
Abstract
Background: The prevalence of intracranial aneurysms (IAs) has been proposed to be elevated in the patients with neurofibromatosis type 1 (NF1). Our aims were to determine the prevalence of NF1 in a large Finnish population based cohort of IA patients and, on the other hand, the occurrences of subarachnoid haemorrhage and unruptured intracranial aneurysms in a nationwide population-based cohort of NF1 patients and its matched ten-fold control cohort.
Methods: The Kuopio IA Database (www.kuopioneurosurgery.fi) includes all ruptured and unruptured IA cases admitted to the Kuopio University Hospital (KUH) from its defined Eastern Finnish catchment population since 1980. In this registry-based study, we cross-linked the Kuopio IA database with the Finnish national registry covering all hospital diagnoses. The NF1 diagnoses of the 4543 patients with either saccular of fusiform IA were identified from 1969 to 2015 and verified from patient records. Our second approach was to analyze the occurrence of aneurysmal subarachnoid haemorrhage (aSAH) and unruptured IAs in a nationwide population-based database of 1410 NF1 patients and its ten-fold matched control cohort (n = 14030) using national registry of hospital diagnoses between 1987 and 2014.
Results: One NF1 patient was identified among the 4543 IA patients. Three verified IA cases (one unruptured IA and two aSAH cases) were identified in the cohort of 1410 NF1 patients, with similar occurrences in the control cohort.
Conclusions: We found no evidence in our population-based cohorts to support the conception that NF1 is associated with IAs. Our results indicate that the incidence of aSAH is not elevated in patients with NF1. Further studies are required to confirm that there is no association between NF1 and unruptured IAs.
Conflict of interest statement
Similar articles
-
Polycystic kidney disease among 4,436 intracranial aneurysm patients from a defined population.Neurology. 2017 Oct 31;89(18):1852-1859. doi: 10.1212/WNL.0000000000004597. Epub 2017 Oct 4. Neurology. 2017. PMID: 28978659
-
Saccular Intracranial Aneurysms in Children When Both Parents Are Sporadic or Familial Carriers of Saccular Intracranial Aneurysms.Neuroepidemiology. 2019;52(1-2):47-54. doi: 10.1159/000493856. Epub 2018 Nov 26. Neuroepidemiology. 2019. PMID: 30476927
-
Epilepsy after aneurysmal subarachnoid hemorrhage: A population-based, long-term follow-up study.Neurology. 2015 Jun 2;84(22):2229-37. doi: 10.1212/WNL.0000000000001643. Epub 2015 May 6. Neurology. 2015. PMID: 25948726
-
Genetic basis of intracranial aneurysm formation and rupture: clinical implications in the postgenomic era.Neurosurg Focus. 2019 Jul 1;47(1):E10. doi: 10.3171/2019.4.FOCUS19204. Neurosurg Focus. 2019. PMID: 31261114 Review.
-
Lack of evidence for an association between neurofibromatosis type I and intracranial aneurysms: autopsy study and review of the literature.Stroke. 2001 Nov;32(11):2481-5. doi: 10.1161/hs1101.098329. Stroke. 2001. PMID: 11692004 Review.
Cited by
-
Co-occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2.Mol Genet Genomic Med. 2020 Aug;8(8):e1321. doi: 10.1002/mgg3.1321. Epub 2020 Jun 13. Mol Genet Genomic Med. 2020. PMID: 32533764 Free PMC article.
-
Neurofibromatosis type 1 with subarachnoid hemorrhage due to multiple and de novo aneurysms: a case report.J Med Case Rep. 2021 Jul 30;15(1):411. doi: 10.1186/s13256-021-02967-3. J Med Case Rep. 2021. PMID: 34325735 Free PMC article.
-
Long-term Risk of Epilepsy in Subarachnoid Hemorrhage Survivors With Positive Family History: A Population-Based Follow-up Study.Neurology. 2023 Oct 17;101(16):e1623-e1632. doi: 10.1212/WNL.0000000000207737. Epub 2023 Aug 29. Neurology. 2023. PMID: 37643884 Free PMC article.
-
Association of Intracranial Aneurysms With Aortic Aneurysms in 125 Patients With Fusiform and 4253 Patients With Saccular Intracranial Aneurysms and Their Family Members and Population Controls.J Am Heart Assoc. 2019 Sep 17;8(18):e013277. doi: 10.1161/JAHA.119.013277. Epub 2019 Sep 5. J Am Heart Assoc. 2019. PMID: 31538843 Free PMC article.
-
An update on the central nervous system manifestations of neurofibromatosis type 1.Acta Neuropathol. 2020 Apr;139(4):625-641. doi: 10.1007/s00401-019-02002-2. Epub 2019 Apr 8. Acta Neuropathol. 2020. PMID: 30963251 Free PMC article. Review.
References
-
- Upadhyaya M, Cooper D. Neurofibromatosis type 1: Molecular and cellular biology. Berlin Heidelberg: Springer-Verlag; 2012.
-
- Stumpf D, Alksne J, Annegers J. Neurofibromatosis. Conference statement. National institutes of health consensus development conference. Arch Neurol. 1988;45:575–578. - PubMed
-
- Jouhilahti E, Peltonen S, Heape AM, Peltonen J. The pathoetiology of neurofibromatosis 1. Am J Pathol. 2011;178:1932–1939. doi: 10.1016/j.ajpath.2010.12.056 - DOI - PMC - PubMed
-
- Rosser T, Vezina G, Packer R. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Neurology. 2005;64:553–555. doi: 10.1212/01.WNL.0000150544.00016.69 - DOI - PubMed
-
- Cairns AG, North KN. Cerebrovascular dysplasia in neurofibromatosis type 1. J Neurol Neurosurg Psychiatry. 2008;79:1165–1170. doi: 10.1136/jnnp.2007.136457 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous